Alcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders

STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer® Lens (ICL) today announced that Alcon (SIX/NYSE: ALC) has exercised its right under the Alcon merger agreement to ...
Medical Device and Diagnostic Industry (MD+DI)

STAAR Shareholder Vote Delayed for Fourth Time

A fourth delay hits Staar Surgical’s shareholder vote on Alcon's $1.6B takeover as Broadwood Partners calls the deal flawed ...

Lensar: Timing And Arbitrage Considerations In Alcon's Acquisition Bid

Alcon Inc.'s acquisition of LENSAR, Inc. remains pending, with an FTC antitrust review likely delaying the closing. Learn ...

STAAR Stockholders Have a Choice: Vote FOR Alcon’s Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create ...

STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today issued the following open letter to ...
Healio

Alcon to acquire Lensar in deal worth up to $430 million

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

STAAR Surgical jumps after Alcon raises offer to $30.75/share in cash (update)

Adds Broadwood comment. STAAR Surgical (STAA) soared 10% after Alcon (ALC) increased its offer for STAAR to $30.75/share in cash. The purchase price increase represents an additional ~$150 million in ...

Swiss eyecare giant Alcon lifts bid for rival Staar

Swiss eyecare giant Alcon has made a new offer for Staar Surgical worth $1.6 billion, it said on Tuesday, as it seeks to clinch a deal despite opposition from Staar's biggest shareholder. The latest ...
Reading Eagle

Alcon announces purchase of STARR Surgical for $1.5 billion

Alcon, an international eye care company with facilities in Berks County, has announced it plans to acquire STAAR Surgical Co. Under the terms of the agreement announced Tuesday, Alcon will purchase ...
Investing.com UK

Exclusive: STAAR merger with Alcon still fails to gain traction, only 30% vote for

For its part, STAAR has advocated for the merger by highlighting ongoing struggles in the Chinese market. The company argues that Alcon’s offer, a 74% premium to STAAR’s 90-day Volume Weighted Average ...
Fort Worth Star-Telegram

Alcon Laboratories is considering a major $100M expansion of its Fort Worth campus

Alcon Laboratories, already one of the largest employers and taxpayers in Tarrant County, is exploring a major expansion of its Fort Worth campus. Alcon, which started in Fort Worth and has grown to ...
FiercePharma

Alcon gains first FDA prescription drug nod since Novartis split, scoring with drops for dry eye disease

Six years after being spun out from Novartis and becoming a public company, eye care specialist Alcon has gained its first FDA approval for a prescription drug, scoring a nod for dry eye disease (DED) ...